Use of serum KL-6 level for detecting patients with restrictive allograft syndrome after lung transplantation

KL-6 is an antigen produced mainly by damaged type II pneumocytes that is involved in interstitial lung disease. Chronic lung allograft dysfunction (CLAD) after lung transplantation (LT) is a major concern for LT clinicians, especially in patients with restrictive allograft syndrome (RAS). We invest...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2020-01, Vol.15 (1), p.e0226488-e0226488
Hauptverfasser: Berastegui, Cristina, Gómez-Ollés, Susana, Mendoza-Valderrey, Alberto, Pereira-Veiga, Thais, Culebras, Mario, Monforte, Victor, Saez, Berta, López-Meseguer, Manuel, Sintes-Permanyer, Helena, Ruiz de Miguel, Victoria, Bravo, Carlos, Sacanell, Judit, Ramon, María-Antonia, Romero, Laura, Deu, María, Román, Antonio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!